InfuSystem Holdings, Inc Financial Summary

Quick Answer

InfuSystem Holdings, Inc reported Total Revenue of $143.44 million for fiscal year 2025.

InfuSystem Holdings, Inc — Key Financials by Year

Metric 2025 2024 2023 2022 2021 2020
Total Revenue $143.44M
+6.4%
$134.86M
+7.2%
$125.78M
+14.4%
$109.91M
+7.4%
$102.38M
+5.1%
$97.39M
+20.1%
Net Income $6.63M
+182.6%
$2.35M
+168.9%
$872.0K
+4744.4%
$18.0K
-98.7%
$1.42M
-91.8%
$17.33M
+1173.5%
Diluted EPS $0.31
+181.8%
$0.11
+175.0%
$0.04 $0.00
-100.0%
$0.06
-92.5%
$0.80
+1042.9%
Total Assets $100.56M
-2.9%
$103.61M
+0.7%
$102.92M
+3.5%
$99.39M
+1.8%
$97.59M
+0.6%
$96.99M
+22.4%
Cash and Equivalents $3.19M
+504.6%
$527.0K
+128.1%
$231.0K
+40.0%
$165.0K
-11.3%
$186.0K
-98.1%
$9.65M
+264.5%
Long-Term Debt $19.62M
-17.8%
$23.86M
-18.0%
$29.10M
-12.2%
$33.16M
+1.2%
$32.75M
+11.5%
$29.38M
-3.0%
Stockholders Equity $57.33M
-0.4%
$57.53M
+10.0%
$52.30M
+9.0%
$48.00M
-0.6%
$48.27M
+18.5%
$40.75M
+82.5%
Operating Income $11.92M
+73.0%
$6.89M
+68.6%
$4.09M
+147.2%
$1.65M
-41.3%
$2.82M
-68.1%
$8.83M
+150.4%
Gross Profit $80.30M
+14.1%
$70.40M
+11.6%
$63.11M
+4.2%
$60.56M
+3.5%
$58.54M
-0.4%
$58.76M
+25.3%
Shares Outstanding 20.21M
-5.0%
21.27M
+0.4%
21.20M
+2.0%
20.78M
+0.4%
20.70M
+2.0%
20.30M
+2.1%

Most Recent Quarter

Metric Quarter Ending Value YoY QoQ
Total Revenue September 30, 2025 $36.49M +3.3% +1.3%
Net Income September 30, 2025 $2.26M +25.0% -13.1%
Diluted EPS September 30, 2025 $0.11 +37.5% -8.3%
Total Assets September 30, 2025 $98.88M -6.1% -2.0%
Cash and Equivalents September 30, 2025 $955.0K +151.3% +32.6%
Long-Term Debt September 30, 2025 $20.93M -25.2% -20.6%
Stockholders Equity September 30, 2025 $55.47M -0.1% +1.7%
Operating Income September 30, 2025 $3.81M +16.7% +0.9%
Gross Profit September 30, 2025 $20.82M +9.3% +4.8%
Shares Outstanding September 30, 2025 20.33M -4.3% -0.5%
  • InfuSystem Holdings, Inc reported Total Revenue of $143.44 million for fiscal year 2025.
  • InfuSystem Holdings, Inc showed an increase of +6.4% in Total Revenue compared to the prior fiscal year.
  • InfuSystem Holdings, Inc reported Net Income of $6.63 million for fiscal year 2025.
  • InfuSystem Holdings, Inc showed an increase of +182.6% in Net Income compared to the prior fiscal year.
  • InfuSystem Holdings, Inc reported Diluted EPS of $0.31 per share for fiscal year 2025.
  • InfuSystem Holdings, Inc showed an increase of +181.8% in Diluted EPS compared to the prior fiscal year.
  • InfuSystem Holdings, Inc reported Total Assets of $100.56 million for fiscal year 2025.
  • InfuSystem Holdings, Inc showed a decrease of -2.9% in Total Assets compared to the prior fiscal year.
  • InfuSystem Holdings, Inc reported Cash and Equivalents of $3.19 million for fiscal year 2025.
  • InfuSystem Holdings, Inc showed an increase of +504.6% in Cash and Equivalents compared to the prior fiscal year.
  • InfuSystem Holdings, Inc reported Long-Term Debt of $19.62 million for fiscal year 2025.
  • InfuSystem Holdings, Inc showed a decrease of -17.8% in Long-Term Debt compared to the prior fiscal year.
  • InfuSystem Holdings, Inc reported Stockholders Equity of $57.33 million for fiscal year 2025.
  • InfuSystem Holdings, Inc showed a decrease of -0.4% in Stockholders Equity compared to the prior fiscal year.
  • InfuSystem Holdings, Inc reported Operating Income of $11.92 million for fiscal year 2025.
  • InfuSystem Holdings, Inc showed an increase of +73.0% in Operating Income compared to the prior fiscal year.
  • InfuSystem Holdings, Inc reported Gross Profit of $80.30 million for fiscal year 2025.
  • InfuSystem Holdings, Inc showed an increase of +14.1% in Gross Profit compared to the prior fiscal year.
  • InfuSystem Holdings, Inc reported Shares Outstanding of 20.21 million shares for fiscal year 2025.
  • InfuSystem Holdings, Inc showed a decrease of -5.0% in Shares Outstanding compared to the prior fiscal year.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment